by Gilles Frydman | Nov 12, 2009
The FDA is holding a public hearing on the “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools.” There is a tremendous amount of buzz on Twitter and blogs about this meeting which will hear 60 speakers, some more than...
by Gilles Frydman | Oct 13, 2009
Note: if you do not use Twitter an explanation of this post’s title may be in order. #WhyPM is the Twitter hashtag we have been using collectively to announce the launch of the Journal of Participatory Medicine and to mention topics of interest from the Journal and...
by Gilles Frydman | Jun 29, 2009
Goodhart’s law – named after a former chief economist of the Bank of England – says that whatever social or economic indicator or other surrogate measure you adopt as a financial target ceases to be a relevant target once you have adopted it because...
by Gilles Frydman | Jun 28, 2009
Guest Post: Cindy Throop from http://Open-Health.us, a participatory forum dedicated to effectively including patients in the discussion, planning, and evaluation of health care reform. A lot of money is about to be invested in health care, particularly into health...
by Gilles Frydman | Jun 22, 2009
Dedication: This post is dedicated to Regina Holliday and to the memory of her husband, Frederick Allen Holliday, who passed away on June 17. Regina’s story has energized many of us to create the Declaration of Health Data Rights we are asking you to endorse on...
Exciting 15th Anniversary Project and Opportunity for Member EngagementAugust 7, 2024
Leveraging Personalized Technology to Motivate Behavior ChangeMay 6, 2024
Technology, Health Equity, and Participatory Medicine in the Care Management of Sickle Cell PatientsApril 26, 2024
Driving Transformation: Change Management Strategies for Integrating Participatory Medicine in HealthcareApril 6, 2024
The Challenge for Medicare Part D Patients: Inability to Utilize Pharmaceutical Programs to Reduce Medication CostsMarch 29, 2024
Recent Comments